BioLabs
BioLabs runs a network of 21 shared laboratory and coworking sites across the United States, Europe and Asia, founded by Johannes Fruehauf.
Industry: Shared laboratory and coworking space for life sciences | Founded: 2009
About BioLabs
BioLabs describes itself as a global innovation infrastructure company that provides shared laboratories, coworking spaces, entrepreneurial programming and connections to industry and capital. It runs a membership-based network of shared lab and office facilities that lets a company start with a single lab bench and scale up.
Johannes Fruehauf, who holds a PhD and an MD, is founder and president. He is also founder and chairman of LabCentral, a life sciences incubator in Cambridge, Massachusetts, and co-founder and general partner of Mission BioCapital, according to the Carnegie Corporation of New York. The company's about page lists Susan Chase as chief business officer, Steven Palmer as chief operating officer and John Freeman as chief financial officer. The pages read do not state when BioLabs was founded.
The company's website lists 21 sites in the United States, Europe and Asia, among them Boston, Cambridge in the United Kingdom, Berlin, Heidelberg, Munich, Paris-Saclay, Tokyo, Kawasaki, San Diego, New York and Toronto. Its home page says BioLabs has supported more than 500 life science companies, that member-launched companies have created more than 1,200 jobs and that member companies have raised more than USD 5 billion. It also reports that BioLabs and its strategic partners have awarded more than 85 Golden Tickets since 2018.
Programmes include BioLabs Academy, with sessions in Osaka and Tokyo, Golden Tickets that provide free lab bench space, sponsor programmes organised by site, investor days, and the Spartners site in Paris-Saclay developed with Servier.
In January 2025 BioLabs, LabCentral and MBC BioLabs announced a five-year strategic partnership with AbbVie. Under it, AbbVie sponsors Golden Tickets giving start-ups one year of free bench space, and resident companies gain access to AbbVie Ventures and to AbbVie research and development experts. The three organisations' networks include more than 500 start-ups in the United States, France and Germany, per the release.
Leadership
- Johannes Fruehauf, Founder and President
- Susan Chase, Chief Business Officer
- Steven Palmer, Chief Operating Officer
- John Freeman, Chief Financial Officer